uniQure N.V. (NASDAQ: QURE) Stock Information | RedChip

uniQure N.V. (NASDAQ: QURE) Listen to this Section


$6.73
+0.0300 ( +0.45% ) 643.5K

uniQure NV is a gene therapy company. It develops treatments and platforms for patients suffering from genetic and other devastating diseases. Its products and services are focused on hemophilia, Huntington's disease, and cardiovascular diseases. The company is focused on the development of the pipeline of gene therapies with the collaboration of Bristol Myers Squibb for cardiovascular diseases.

Market Data


Open


$6.73

Previous close


$6.70

Volume


643.5K

Market cap


$327.74M

Day range


$6.69 - $7.00

52 week range


$3.73 - $11.35

Insider Ownership Transactions

Total Amount Purchased: -62,554.00 | $ -420,988.42

Date Type Amount Purchased Purchaser
2024-06-28 Sale -1447.00 Abi-Saab Walid
2024-06-21 Sale -8080.00 Kaye Jack
2024-06-21 Sale -8080.00 Springhorn Jeremy P.
2024-06-21 Sale -8080.00 Jacques Rachelle Suzanne
2024-06-21 Sale -8080.00 Meek David D.
2024-06-21 Sale -8080.00 Gut Robert
2024-06-21 Sale -8080.00 POST LEONARD E
2024-06-21 Sale -8080.00 Balachandran Madhavan
2024-06-20 Sale -2936.00 CALOZ PIERRE
2024-06-20 Sale -1611.00 KLEMT CHRISTIAN

SEC Fillings


Form Type Description Pages Date
8-k 8K-related 15 Aug 15, 2024
10-q Quarterly Reports 72 Aug 01, 2024
8-k 8K-related 15 Aug 01, 2024
8-k 8K-related 15 Jul 23, 2024
8-k 8K-related 15 Jul 09, 2024
8-k 8K-related 15 Jul 01, 2024
4 Insider transactions 1 Jun 28, 2024
4 Insider transactions 1 Jun 21, 2024
4 Insider transactions 1 Jun 21, 2024
4 Insider transactions 1 Jun 21, 2024

Latest News


Terms and Agreement

Please agree to the terms to continue using the chat feature.